Comparative performance of large language models and Drugs.com versus Lexicomp for antiseizure medication drug–drug interactions: A cross-sectional study with iterative prompting analysis
Open accessAbstract
Antiseizure medications (ASMs) are frequently co-prescribed and are associated with a high risk of clinically significant drug–drug interactions (DDIs). Large language models (LLMs) are increasingly used for clinical queries, yet their performance in detecting ASM-related DDIs compared with established drug interaction databases remains uncertain. A cross-sectional comparative study evaluated 186 ASM–comedication pairs (126 classified as major/moderate by Lexicomp) using ChatGPT-4, DeepSeek-V3, and Drugs.com , with Lexicomp as the reference standard. Interactions were assessed for presence, severity, mechanism, and management recommendations. Major and moderate interactions were classified as clinically relevant for performance analysis. A post hoc iterative prompting analysis was conducted exclusively on false positive cases to assess improvements in specificity. Performance metrics included sensitivity, specificity, predictive values, and overall accuracy. Two clinical pharmacists independently assessed outputs for accuracy, clarity, and completeness, with adjudication by a third pharmacist. Drugs.com demonstrated the best overall performance, with sensitivity 0.870, specificity 0.629, and accuracy 0.709. ChatGPT showed high sensitivity (0.842) but low specificity (0.358), reflecting frequent over prediction of interactions. Low specificity reflected frequent overclassification of non-interacting or minor pairs as clinically relevant, potentially leading to alert fatigue, unnecessary monitoring or therapeutic modification. DeepSeek achieved the highest sensitivity (0.877) but the lowest specificity (0.200) and the greatest number of false positives. Iterative prompting substantially improved specificity for ChatGPT (0.77) and DeepSeek (0.42), correcting many false positive classifications. ChatGPT and DeepSeek provided broad interaction overviews but demonstrated limited specificity under single-prompt conditions. Structured, evidence-constrained prompting improved specificity in false positive cases within this dataset. Drugs.com showed the most balanced performance compared with zero-shot LLM outputs. At present, LLMs may serve as supplementary explanatory tools, whereas structured drug interaction databases remain more reliable for primary DDI screening. • Drugs.com showed the highest accuracy among tested tools for AED interactions in primary analysis. • Initial, single-prompt queries with ChatGPT and DeepSeek produced a high rate of false positives due to low clinical specificity. • Iterative (multi-step) prompting significantly improved the specificity of both ChatGPT and DeepSeek, correcting many false positives. • Iterative prompting is key to improving clinical precision and reducing the over-prediction of interactions by large language models. • Evaluators rated Drugs.com highest in completeness and ChatGPT best in clarity. • AI tools are useful for support, but require iterative, evidence-focused prompting to increase precision and should not be relied upon for independent clinical use.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In another study, ChatGPT-3.5 was less accurate when the required answers were not based on publicly available information.
“whilst in another study, ChatGPT-3.5 was less accurate when the required answers were not based on publicly available information.91”
From Large Language Models in Pharmacist-Led Direct Patient Care: A Rapid Review of Published Evaluations (2026) · cites this paper as [91]
The Methods (Data collection procedure; page unavailable) say the authors chose ChatGPT-4 because it had higher sensitivity and specificity than ChatGPT-3.5. The paper does not say ChatGPT-3.5 was less accurate specifically when answers depended on information that was not publicly available; searches for that condition found no supporting passage. (LLM, conf=0.77)
Experimental — accuracy not yet measuredChatGPT-3.5 performed adequately in providing medication information but had poor performance in recognizing adverse drug reactions and on high-complexity tasks.
“In other studies, ChatGPT-3.5 was reported to have performed adequately in providing medication information, 32,55 but had poor performance in J o u r n a l P r e -p r o o f recognizing adverse drug reactions and similar poor performance on high-complexity tasks.55,91,92”
From Large Language Models in Pharmacist-Led Direct Patient Care: A Rapid Review of Published Evaluations (2026) · cites this paper as [91]
The Methods (Study design and Data collection procedure; page unavailable) specify that the study evaluated ChatGPT-4, not ChatGPT-3.5. The Results report performance on antiseizure-medication drug interactions, but no passage found assesses ChatGPT-3.5’s provision of medication information, recognition of adverse drug reactions, or performance on high-complexity tasks. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Antiepileptic drug interactions—Principles and clinical implications
I. Johannessen, S., & Johannessen Landmark, C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246254 · Cited by 343 · see citing works
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs
Zaccara, G., & Perucca, E. (2014) · Epileptic Disorders · doi:10.1684/epd.2014.0714 · Cited by 311 · see citing works
Namazi, S., Kheshti, R., & Aalipour, M. (2016) · Journal of Research in Pharmacy Practice · doi:10.4103/2279-042x.192461 · Cited by 224 · see citing works
Neurotoxins: Free radical mechanisms and melatonin protection
J. Reiter, R., C. Manchester, L., & Tan, D.-X. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246236 · Cited by 179 · see citing works
Impact of large language model (ChatGPT) in healthcare: an umbrella review and evidence synthesis
Iqbal, U., Tanweer, A., Rahmanti, A. R., Greenfield, D., Lee, L. T.-J., & Li, Y.-C. J. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01131-z · Cited by 135 · see citing works
The Capability of ChatGPT in Predicting and Explaining Common Drug-Drug Interactions
Juhi, A., Pipil, N., Santra, S., Mondal, S., Behera, J. K., & Mondal, H. (2023) · Cureus · doi:10.7759/cureus.36272 · Cited by 131 · see citing works
Al-Ashwal, F. Y., Zawiah, M., Gharaibeh, L., Abu-Farha, R., & Bitar, A. N. (2023) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s425858 · Cited by 125 · see citing works
Prompt Engineering in Clinical Practice: Tutorial for Clinicians
Liu, J., Liu, F., Wang, C., & Liu, S. (2025) · Journal of Medical Internet Research · doi:10.2196/72644 · Cited by 76 · see citing works
Benzodiazepine use in seizure emergencies: A systematic review
Haut, S. R., Seinfeld, S. A., & Pellock, J. M. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.07.018 · Cited by 70 · see citing works
DeepSeek vs. ChatGPT: prospects and challenges
Jin, I., Tangsrivimol, J. A., Darzidehkalani, E., Virk, H. U. H., Wang, Z., Egger, J., Hacking, S. M., Glicksberg, B. S., Strauß, M., & Krittanawong, C. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1576992 · Cited by 60 · see citing works
Comparison of Nine Tools for Screening Drug-Drug Interactions of Oral Oncolytics
Marcath, L. A., Xi, J., Hoylman, E. K., Kidwell, K., Kraft, S. L., & Hertz, D. L. (2018) · Journal of Oncology Practice · doi:10.1200/jop.18.00086 · Cited by 53 · see citing works
Kunitsu, Y. (2023) · JMIR Medical Education · doi:10.2196/48452 · Cited by 45 · see citing works
Prescription pattern of antiepileptic drugs in a tertiary care center of India
Gupta, Y., Joshi, R., Tripathi, M., Gupta, P., & Gulati, S. (2020) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_507_17 · Cited by 30 · see citing works
Radha Krishnan, R. P., Hung, E. H., Ashford, M., Edillo, C. E., Gardner, C., Hatrick, H. B., Kim, B., Lai, A. W. Y., Li, X., Zhao, Y. X., et al. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16275 · Cited by 29 · see citing works
Chat GPT vs. Clinical Decision Support Systems in the Analysis of Drug–Drug Interactions
Bischof, T., al Jalali, V., Zeitlinger, M. A., Jorda, A., Hana, M., Singeorzan, K.-N., Riesenhuber, N., Stemer, G., & Schoergenhofer, C. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3585 · Cited by 27 · see citing works
Bossaer, J. B., Eskens, D., & Gardner, A. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155220984244 · Cited by 25 · see citing works
Epilepsy in Qatar: Causes, treatment, and outcome
Haddad, N., Melikyan, G., Hail, H. A., Jurdi, A. A., Aqeel, F. F., Elzafarany, A., Abuhadra, N. K., Laswi, M., Alsamman, Y., Uthman, B. M., et al. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.07.043 · Cited by 23 · see citing works
Thapa, R. B., Karki, S., & Shrestha, S. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100564 · Cited by 19 · see citing works
Liang, C., Chiang, K.-L., Hsieh, L.-P., & Chien, L. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108450 · Cited by 17 · see citing works
Celis, P., Farinelli, G., Hidalgo‐Simon, A., Meij, P., Tihaya, M. S., Schüßler‐Lenz, M., & Timón, M. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16047 · Cited by 13 · see citing works
Thakkar, V., Silverman, G., Kc, A., Ingraham, N. E., Jones, E., King, S., Melton, G. B., Zhang, R., & Tignanelli, C. J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323535 · Cited by 7 · see citing works
Domián, B. M., Ashraf, A. R., Fittler, A. T., Káplár, M., & Vida, R. G. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100655 · Cited by 6 · see citing works
Anti-seizure medication prescription preferences: a Moroccan multicenter study
Naji, Y., Hrouch, W., Laadami, S., & Adali, N. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1435075 · Cited by 2 · see citing works
Pant, P., Thapa, S., Karkee, S. B., & Pandey, S. (2024) · International Journal of Epilepsy · doi:10.1055/s-0044-1791263 · Cited by 2 · see citing works
Bukola, S. A., Anyom, O. U., Sangha, S. B., & Imonifano, E.-O. (2025) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2025.26.3.2282 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [11]Kluwer Wolters Lexicomp Online, Wolters Kluwer Clinical Drug Information, Hudson, OH https://www.lexicomp.com 2025 (accessed 11 June 2025)
Cited by
Sorted by citations
Large Language Models in Pharmacist-Led Direct Patient Care: A Rapid Review of Published Evaluations
Yakob, R. A., Bamgboje-Ayodele, A., Collins, J. C., & Aslani, P. (2026) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2026.09.007
Khan, M. A., Maazuddin, M., Abdullah, A. A., Sultan, I., Alzaeem, H. A., Qintar, M., Sharma, K. K., & Pal, B. (2026) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-026-02203-2
Self-citationЈаnkovic, S., Jovanović, M. T., & Nedin-Ranković, G. (2026) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2026.2738609
- Authors
- Mohammed, M., Khan, M. A., Chaudhary, V., Alsaleh, H., Fatima, S. B., & Pal, B.
- Affiliations
- Lovely Professional University (IN)
- Hamad Medical Corporation (QA)
- Corresponding author
- Pal, Biplab
- Venue
- Exploratory Research in Clinical and Social Pharmacy
- Publisher
- Elsevier BV
- Published
- 2026-06
- Volume
- 22
- Pages
- 100733
- ISSN
- 2667-2766 (ISSN-L)
- PMC
- PMC13081677
- OpenAlex
- W7140309989
- Cited by
- 2
- References
- 18
- Citations by year
- 2026: 2
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Exploratory Research in Clinical and Social Pharmacy (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Keywords
- antiepileptic drugs, drug-drug interactions, large language models, ChatGPT, DeepSeek, Drugs.com, Lexicomp, iterative prompting, false positives, specificity, alarm fatigue, drug interaction databases, co-prescription, clinical decision support, pharmacovigilance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review